|
Ozone is a gas which is an
allotropic and a more active form of oxygen. The term comes
from the Greek for stench since there is an odor associated
with ozone. Ozone is essentially oxygen with an extra molecule of
oxygen making it O3. Ozone (O3) is heavier
than regular oxygen (O2). It quickly breaks down to
oxygen (O2) in approximately twenty minutes. The free
atom released in the breakdown of ozone does have to attach to
another gas and does so readily. It is this need to attach to
another molecule of another gas or substance that we use in
medicine.
Ozone in the
atmosphere is formed when oxygen is exposed to the silent discharge
of electricity. It can be both irritating to the pulmonary system
and toxic in sufficient quantities. However, in ordinary medical
quantities it is not irritating and, on the contrary, can be quite
beneficial. Ozone only gets a bad name due to the fact that
we use ozone as a measure of other ingredients in the
atmosphere. It is usually not the ozone itself that is harmful but
the other particles in the air that are harmful. Remember that we
have technology to measure ozone but not all particles floating in
the air. So, we use ozone to detect other particle
presence.
Ozone has been in
use in one form or another since the early 1900s. Its’ use has
evolved as knowledge has evolved both commercially and
medically. You will see much information available about self
help procedures elsewhere. The ozone procedures done at this office
are medical procedures.
However, usually
there are also other medical problems and needs that need to be
addressed that ozone alone will not help or solve. So, in this
office we will evaluate the use of the procedure with your current
health and medical problems.
Ozone is an
antiseptic and disinfectant used in a variety of different places in
modern society. It is used in swimming pools, hot tubs, municipal
and home water filtration, air cleaners.
Ozone therapy in
this country is relatively unknown. However, in other parts of the
world it is used commonly. There is a clinical trial for asthma
currently in the research stage here in the United States sponsored
by the National Institute of Environmental Health Sciences with the
location being at Johns Hopkins School of Hygiene and Public Health
in Baltimore, Maryland.
Medical infusion
procedures are able to extract the benefits of ozone
and oxygen more directly than through other modalities such
as the skin, pills or creams or other non medical procedures
available to the general public. The procedures are generally not
covered by insurance. However, your health is your own decision. It
is also your decision how you spend the money that you
earn.
Call this office
and make an appointment to discuss your individual needs with the
doctor. Each patient has individual problems and requirements which
require medical evaluation.
Ozone in Medicine: Overview and
Future Directions
By Gerard V. Sunnen, M.D.
Abstract:
Ozone, an
allotropic form of oxygen possesses unique properties which are
being defined and applied to biological systems as well as to
clinical practice. As a molecule containing a large excess of
energy, ozone, through incompletely understood mechanisms, manifests
bactericidal, virucidal and fungicidal actions which may make it a
treatment of choice in certain conditions and an adjunctive
treatment in others.
Introduction
Ozone, best known
for its protective role in the earth’s ecological harmony, and for
its interaction at ground level with industrial pollutants, has
unique biological properties which are being investigated for
applications in various medical fields.
As early as the
First World War, ozone’s bactericidal properties were used to treat
infected wounds, mustard gas burns and fistulas. These first
treatment attempts, however, were hampered by technological
difficulties. Medical ozone generators have since been developed and
refined. They differ from industrial generators in their capacity to
deliver the purest ozone-oxygen mixtures in precise dosages. A
critical advance in medical ozone technology was the development, in
the early 60’s, of plastics which can adequately conduct this
mixture and permit proper interfacing with patients. In the last few
years ozone treatment has seen growing interest from diverse medical
discipline, and research is in progress to delineate its effects on
biological systems and to define its clinical
applications.
Historical
Perspectives
The history of
ozone’s discovery is intrinsically entwined in the evolution of the
earliest concepts in chemistry. Priestly and Cavendish noted that
electrical sparks fired in a closed volume of air resulted in volume
compression.[1,2] In 1785, Martinus Van Marum, subjecting oxygen to
electrical discharges, noted “the odor of electrical matter” and the
accelerated oxidation of mercury. In 1840, Schonbein repeated these
experiments, concluded that this odor was due to a gas which he
named ozone, from the Greek ozein (odorant), and described several
of its properties.[3] Numerous researchers since that time have
worked to elucidate the nature and actions of ozone. Still today,
theoretical issues remain regarding its electron structure, the
varieties of it molecular configurations and its kinetics. Mariniak
and Delarive showed that it is an allotropic form of oxygen, and
Mulliken and Dewar clarified its molecular
architecture.[4]
In the latter part
of the 19th century, ozone was found to oxidize a
spectrum of organic compounds and to interact with double bonds.
Chemists made use of these properties to study complex molecules by
cleaving them into smaller fragments. Harries, by such methods,
discovered the structure of natural rubber.[4]
The ability of
ozone to destroy toxic or noxious industrial impurities (phenols,
cyanides, tetraethyl lead among others) and to inactivate bacterial
contaminants in sewage has made it an attractive alternative to
chlorination. Wiesbaden, Germany became the first city to use
ozonation for purification of its drinking water (1901), followed by
Zurich, Florence, Brussels, Marseille, Singapore and Moscow (the
largest installation in the world), among others. The history of
ozone’s medical applications has nebulous and anecdotal beginnings.
Kleinmann is said to have carried out the first bacteriological
studies on pathogenic organisms using the Siemens tube, shortly
after its invention.[5] Payr,[6] and Fisch and Wolff[7] were
clinician pioneers, and J. Hansler developed one of the first
reliable models of medical ozone generators.[5,8]
Physico-Chemical and Biochemical
Properties
The
oxygen atom exists in nature in several forms: (1) as a free atomic
particle (O), it is highly reactive and unstable; (2) oxygen
(O2) its most common and stable form, is colorless as a
gas and pale blue as a liquid; (3) ozone (O3), has a
molecular weight of 48, a density one and a half times that of
oxygen and contains a large excess of energy in its molecule
(P3--) 3/2 O2 + 143 KJ/mole. It has a bond
angle of 127[3], which resonates among several forms, is distinctly
blue as a gas and dark blue as a solid; (4) O4 is a very
unstable, rare, nonmagnetic pale blue gas which readily breaks down
into two molecules of oxygen.
Ozone is a
powerful oxidant, surpassed in this regard only by fluorine.
Shonbein,3 in 1855, discovered that it reacts with ethelene.
Exposing ozone to organic molecules containing double or triple
bonds yields many complex and as yet incompletely configurated
ephemeral transitional compounds (zwitterions, molozonides, cyclic
ozonides), which may be hydrolyzed, oxidized, reduced or thermally
decomposed to a variety of substances, chiefly aldehydes, ketones,
acids or alcohols. Ozone reacts with saturated hydrocarbons, amines,
sulfhydryl groups and aromatic compounds.
Of importance to
biological systems is ozone’s interaction with tissue (especially
blood) constituents. The most studied is lipid peroxidation although
interactions have yet to be more fully investigated with complex
carbohydrates, protein, glycoproteins and sphingolipids. These
dynamics are especially relevant for medical applications because
some of the most practiced methods in ozone therapy involve the
mixing of a small volume of whole blood with a pure oxygen ozone
mixture and subsequently returning it to the patient. In this
manner, it is calculated that the dose of ozone administered will
perform its therapeutic functions without disrupting blood
constituents.
Since there are a
variety of lipid components in whole blood, it is of more than
theoretical interest to determine the end products of ozone per
oxidation and their effects, not only on physiological systems but
on the integrity of ambient patholgenic organisms, since one of the
mechanisms of viral inactivation is thought to be through this
modality. Cholesterol accounts for 120 to 220 mg/100 ml, of which
60% to 75% are cholesterol esters; phospholipids 9 to 16 mg/100 ml;
triglycerides 40 to 150 mg/100 ml, and free fatty acids 6 to 16
mg/100 ml. Given a total lipid concentration of 450 to 1000 mg/100
ml and the large variety of lipid constituents, the possible end
products of ozonation are bountiful.[9,10]
This question is
further complicated by the presence of systems to buffer lipid
peroxidation, including vitamin E, uric acid,[11] and enzymes such
as superoxide dismutase, catalase, and the glutathione peroxidase
system which has gathered the most experimental
attention.[12]
Several agents
derived from lipid peroxidation include free radical, singlet
oxygen, hydrogen peroxide, hydroperoxide, ozonides, carbonyls,
alkanes and alkenes. Of these, lipid hydroperoxides, the most
extensively studied, are known in sufficient concentrations to
manifest their toxicity by altering cell membranes. Acted upon by
glutathione peroxidase, they are reduced to their corresponding
alcohols.
Method of Manufacture and
Precautions
The production of
ozone-oxygen mixtures for human and veterinary applications is
subject to important technical consideration and standards. Clinical
ozone generators which regulate the flow of medical grade oxygen
through high voltage tubes with outputs ranging from 4000 V to 14000
V are capable of producing precise ozone-oxygen mixtures within
concentration ranges extending to 5%, predicated on three variables:
(1) the voltage applied; (2) the oxygen flow rate; and (3) the
electrode separation distance. The purity of the oxygen source is
especially emphasized since nitrogen, in the presence of high energy
fields, forms toxic nitric oxides.
Since the half
life of ozone is 45 minutes at 20C (68F), losing its concentration
to 16% of its initial value in two hours, it must be freshly
generated for immediate use at the treatment site. The maximum dose
generated, 5% ozone to 95% oxygen, is well below the explosive limit
(15 to 20%). Caution is needed not to appose ether and an ozone, an
especially reactive mixture.
Listed
contraindications to ozone treatment[5] include acute alcohol
intoxication, recent myocardial infarction, hemorrhage from any
organ, pregnancy, hyperthyroidism, thrombocytopenia and ozone
allergy.
Methods of
Administration, Dosage, and Clinical Applications External Ozone Gas
Application
Historically,
ozone was first administered by application to external body sufaces
to determine its effects on a variety of lesions, A. Wolff,[13] in
1915, is credited for using local ozone treatments for wounds,
fistulas, decubitus ulcers and osteomyelitis. Like natural rubber
which cracks and fritters when exposed to oxygen-ozone mixtures,
early materials caused ozone to “bag” around skin surfaces and met
with early oxidation disuse. Today, specially designed plastics
(Teflon) enable extremities or portions of the head or torso to be
comfortably encased in a space where a determined dosage ratio of
oxygen to ozone is administered at a chosen flow rate. In this way,
the walls of the transparent bags do not touch the patient, and
important consideration in burn treatment.
Indication for
external ozone application include poorly healing wounds, burns,[14]
staphylococcal infections, fungal and radiation lesions, herpes
simplex and zoster, and gangrene (diabetic or Clostridium). Dosage
is adjusted to the condition treated. Gas perfusions may last from 3
to 20 minutes, ozone concentrations varying from 10 to 80 ug/ml
(maximum five parts of ozone to 95 parts of oxygen). High ozone
concentrations are used for disinfection and cleaning (or
debridement), while low concentrations promote epithelialization and
healing.[6,15]
Ozone Insufflation
Payr in 1935[6]
and Aubourg in 1936[16] first used ozone-oxygen mixtures in rectal
insufflation to treat ulcerative colitis and fistulae. The list of
indications has expanded to include proctitis and hemorrhoids. It is
reported that in inflammatory diseases of the bowel, ozone promotes
healing and restores the flora balance disturbed by pathogenic
organisms. In a typical treatment for ulcerative colitis, daily
insufflations are applied starting with 50 ml in severe cases,
increasing as tolerated in increments (till 500 ml), high
concentrations administered initially (75 ug/ml) to achieve
hemostasis, followed by low concentrations to promote resolution.[5]
This technique may have some promise in the treatment of bowel
infections associated with AIDS.
Microsporidia, a
tiny, rarely detected parasite may be responsible for many cases of
AIDS wasting illness,[17] and studies await determination of its
susceptibility to ozone treatment.
Major
Autohemotherapy (AHT)
Whereas it can be
readily understood that external ozone applications produce local
effects such as disinfection, wound healing or local circulatory
enhancement, the technique of introducing ozone into the circulation
poses more complex theoretical issues. In the technique of major
autohemotherapy, 50 to 100 ml of blood is drawn from the patient,
mixed with a dose of ozone-oxygen of a predetermined concentration,
then returned via the same intravenous catheter (butterfly).
Returned to the patient, the ozonated blood is rapidly distributed
to all tissues.
In the treatment
aliquot of blood, it is gauged that the dose of ozone given not only
will exert therapeutic actions locally (virucidal activity,
oxygenation, increased red cell fluidity), but will determine
beneficial systemic actions.[18]
The duration of time that ozone remains
in solution and its effects on endocrine, neurological, and
immunological systems are not known. Clinically, some patients, upon
receiving their own ozonated blood, report a faint background taste
of ozone, which may be an indication of its survivability in
solution for at least a few seconds.
Major autohemotherapy has been applied
to the treatment of several conditions, including acute and chronic
viral infections (hepatitis), some carcinomas, circulatory
disturbances (diabetes, arteriosclerosis), and
hyperlipidemia.[8,19-21] Added to a standard pharmacotherapeutic
regimen for postmenopausal osteoporosis, this technique enhanced
remineralization of bone.[22] Clinical reports however, need to be
substantiated by properly designed studies. Of interest are the
reports of some patients, who after receiving this treatment
experience feelings of well-being lasting for a few minutes to
several hours. Whether this represents a placebo effect, a metabolic
alteration or possibly a neuropsychiatric mechanism remains to be
determined.
Miscellaneous
Applications
Although the above techniques of ozone
administration represent the majority of hospital or office-based
procedures, others deserve mention.
Minor
Autohemotherapy
In this technique,
10 ml of venous blood is drawn from the patient, mixed with
ozone-oxygen, then injected intramuscularly. Listed indications
include asthma, acne, some allergic conditions and some
carcinomas.[18,23,24]
Direct
Intra-arterial or Intravenous Administration
Mostly of historical
interest, this method was first used by Iacoste in 1951[25] for
circulatory compromise and its possible sequelae (gangrene). Up to
10 ml of pure ozone-oxygen may be slowly injected directly into the
artery (usually femoral), or into a vein, without incurring
embolization since both gases are readily soluble in blood.[20]
Indications include intermittent claudication, leg ulcers and
cerebral vascular insufficiency. Due to accidents produced by too
rapid introduction of the gas mixture into the circulation, this
technique is now rarely used.
Intramuscular
Injection
Up to 10 ml of pure
ozone-oxygen mixture is injected into the gluteus maximus muscle or
the deltoid. This treatment along with major autohemotherapy is
invoked as an adjunct to cancer
therapy.[15,18,26,27]
Ozonated
Water
Ozone is approximately 10 times more
soluble in water than oxygen. Mixed into aqua bidestillata (pyrogen
free) water, the half life of ozone is nine to ten hours (at pH 7
and 20C); and at 0C, it is doubled. Ozonated water finds
applications in dental surgery where it is reported to promote
hemostasis, enhance local oxygen supply and inhibit bacterial
proliferation. Applied following tooth extraction or during dental
surgery,[28] it may also be rinsed in conditions such as thrush and
periodontal disease, swallowed in cases of gastritis or gastric
carcinoma, or irrigated in chronic intestinal or bladder
inflammation.
Ozone
Ointments
Ozonated olive oil provides long term,
low dose exposure of ozone and lipid peroxides to tissues. Decubitus
ulcers and mycoses are indications for its
use.[29,30]
Balneotherapy
Ozonated water bubbled in warm baths,
provides stimulation of local circulation and disinfectant action to
varicosities, peripheral circulatory disorders and dermatological
conditions (eczema, ulcers).[5]
Blood
Purification
The possibility of using ozone to
sterilize blood supplies has been investigated by several
authors.[7,31] The treatment of 500 ml of whole blood with 100 ml of
O3/O2 mixture (40 to 50 ug/ml) is reported to
render it virus-free without injuring any cellular elements. One
study[31] examined 10,000 samples and found no cases of hepatitis
transmission. This technique may extend its efficacy to the HIV
virus as one preliminary unpublished study indicates although once
ensconced in the genetic cellular material, it is unclear how any
agent could inactivate it without compromising cellular
integrity.
Metabolic and
Physiological Effects of Ozone
Most research on ozone’s biological
effects have concentrated on pulmonary responses with emphasis on
its toxicity. Interest has been keen on ozone’s role in ground level
atmospheric pollution. Produced as a result of interactions between
industrial gases, oxygen and ultraviolet rays, there is evidence of
synergistic action on pulmonary compromise. The effects of pure
ozone, however, need to be differentiated from those of
smog.
The majority of
studies have been performed on animals who show great interspecies
variability in their response to inhaled ozone. Extrapolation to
humans is difficult due to differences in pulmonary anatomy and
physiology. Mice[32] seem to be the most sensitive (LD50, 22 ppm for
3 hrs) and birds[33] the least (turkeys survived 417 ppm ozone for 3
hrs). While overdose is marked by pulmonary edema and hemorrhage,
long term, low level exposure produces poorly understood, sometimes
contradictory findings.
Reported effects[34] include enhanced
enzyme activity, as evidenced by increase in glucose utilization,
lactate and CO2 formation and elevated
glucose-6-phosphate dehydrogenase; an increase in the
NADPH-cytochrome P-450 content in rat lung pointing to enhancement
of metabolizing enzymes; increased lung fibroblast glucose uptake,
and production of lactate and pyruvate.
Humans exposed to
ambient ozone (0.24 ppm in room air for two hours) typically develop
mild accelerated breathing in the context of symptoms such as
tracheal or laryngeal irritation and chest tightness on inspiration.
Large intersubject response differences are notable.[35]
Athletes[36] performing moderate intermittent exercise show a 7%
drop in Forced Vital Capacity (FVC) and a 15% reduction in Forced
Expiratory Volume (FEV). The threshold for significant changes in
respiratory compromise ranges from 0.15 ppm[37] to 0.25 ppm,[38]
increasing ozone concentrations yield corresponding airway
hyper-responsiveness through bronchoconstriction. Histological
findings extrapolated from primate research points to ciliated cell
inhibition and type 2 cell proliferation, increased membrane
permeability and variable inflammatory response.[12] Reported
biochemical alterations[39] include increased oxygen consumption and
glucose utilization; activation of NADPH, superoxide dismutase, GSH
peroxidase, GSH reductase and glutathione peroxidase. Pulmonary
effects from ozone in low doses appear to include metabolic
activation of lung cells while higher doses produce evidence of
cellular metabolic compromise.
In the methodology of ozone treatment,
care is given to avoid the escape of ozone into the treatment area
and modern machines are equipped to catalytically convert excess
ozone to oxygen during administration. Interestingly some studies
point to possible beneficial effects of low dose ambient
ozone.[40,41] The phenomenon of ozone tolerance or adaptation the
response to ozone exposure decreasing with time and finally evolving
to a plateau occurs in both humans and animals.[38] Its significance
remains obscure.
For the reason that
below 0.30 ppm the probability of ozone traversing the respiratory
epithelium and entering the systemic circulation is so low, very few
studies have attempted to measure these effects.[39] In the
technique of major autohemotherapy and others that involve the
direct introduction of ozone into the circulation, however, this
question is of special relevance. Studies of human blood in young
adult males exposed to 0.50 ppm ozone for 2-3/4 hours[42] show
significant changes in erythrocytes (RBC) as well as in the serum.
RBC membrane fragility, glucose-6-phosphate dehydrogenase and
lactate dehydrogenase enzyme activities were increased, while RBC
acetyl cholinesterase and reduced glutathione reductase were not
significantly changed. Serum vitamin E and lipid peroxidation levels
were significantly increased. These findings indicate that ozone
exposure increases metabolic activation parameters in red blood
cells.
According to other
researchers,[20,24,43] the direct intravascular injection of pure
oxygen-ozone mixtures results in the following responses: (1) an
activation of enzymes involved in peroxide or erythrocytes, an
outgrowth of which is (2) stimulation of the[2,3]
Bisphosphoglycerate cycle, shifting the oxyhemoglobin dissociation
curve to the right thus releasing oxygen to the tissues. Further
physiological effects include (3) an enhanced oxidative
decarboxylation of pyruvate with the formation of Acetyl-CoA, and
consequent citric acid cycle activation, (4) a direct influence on
the mitochondrial transport system with reduction of NADH and
oxidation of cytochromes, and (5) an increase in RBC pliability,
blood fluidity, and arterial
PO2.
Mechanisms of
Bactericidal, Virucidal and Fungicidal Action
Although the inhibitory and lethal
effects of ozone on pathogenic organisms have been observed since
the latter part of the 19th century, the mechanisms for
these actions have not yet been satisfactorily elucidated. Ozone is
a strong germicide needing only a few micrograms per liter for
measurable action. At a concentration of 1 g/m3 H2O at
1C, ozone rapidly inactivates coliform bacteria, staphylococcus
aureus and Aeromonas hydrophilia.[44]
The inactivation
rate of enteroviruses[45] is more rapid than for E. coli, takes
place in relatively small concentrations of ozone, and is influenced
by pH, temperature, and the presence of ambient organic
compounds.
Viruses differ in their susceptibility
to destruction by ozone. The resistance of polio virus type 2 was 40
times that of coxsackie AS,[46,47] and in an experiment using a
continuous flow mixed reactor under controlled laboratory
conditions, relative resistance in descending order was found to be:
polio virus type 2, echovirus type 1, polio virus type 1, coxsackie
virus type B5, echovirus type 5, coxsackie virus type A9. In pure
water, at maximal solubility of ozone and room temperature,
Echovirus type 29 is inactivated in one minute, polio virus type 1
in two, type 3 in three and type 2 in seven
minutes.
The cell envelope of Gram negative
microorganisms such as E. coli is a complex multiplayer system
composed of an inner cytoplasmic membrane made of phospholipids and
proteins invaginating into the cytoplasm, a peptidoglycan layer, and
an outer membrane of polymers such as polysaccharides. Gram
positive cells have a less complex, three layer envelope with a
thick peptidoglycan middle layer.
The most cited explanation for ozone’s
bactericidal effects centers on disruption of envelope integrity
through peroxidation of phospholipids and lipoproteins. There is
evidence for interaction with proteins as well.[48] In one study[49]
exploring the effect of ozone on E. coli, evidence was found for
ozone’s penetration of the cell membrane, reacting with cytoplasmic
substances and converting the closed circular plasmid DNA to open
circular DNA, which would presumably lessen the efficiency of
bacterial proliferation. It is notable that higher organisms have
enzymatic mechanisms to restabilize disrupted DNA and RNA, which
could provide a partial explanation for why, in clinical treatment
with ozone at doses prescribed, ozone appears to be toxic to
infecting organisms and not to the
patient.[50]
Ozone possesses fungicidal effects,
through poorly understood mechanisms. In one study, Candida utilis
cell growth inhibition with ozone was greatly dependent on phases of
their growth, budding cells exhibiting the most sensitivity to its
presence.[51] Interestingly, in another study,[52] low doses of
ozone stimulated the growth and development of Monilia fructagen and
Phytophtora infestans, while higher doses were
inhibitory.
Viruses are parasites at the genetic
level, separated into families based on their structure, type of
nucleic genome and mode of replication. Many virions contain a
phospholipid envelope with glycoprotein spikes, encasing the
nucleocapsid which contains nucleic acids (DNA or RNA), and
structural proteins (including
enzymes).
Lipid-containing viruses are sensitive
to treatment with ether, assorted organic solvents, and ozone,
indicating that disruption or loss of lipids results in impaired or
destroyed infectivity. Viruses containing lipid envelopes include
the Herpes viridae a large family grouping the Simplex,
Varicella-Zoster, Cytomegalovirus and Epstein-Barr viruses; the
Paramyxoviridae (mumps, measles); the Orthonyxoviridae (influenza);
the Rhabdoviridae (rabies); and the Retroviridae (HIV). The HIV
virus has an outer envelope made of a double layer of lipids
penetrated by proteins of several types encasing two molecules of
RNA.[53]
Many of the above
viruses have complex, sometimes baffling life cycles and replicative
strategies with progressions from host cell attachment of the virus
particle, to penetration, uncoating of the viral envelope, synthesis
of molecular components, and release of new generations of virions
to the surrounding medium, most often through cell lysis. Many
chronic viruses have eclipse phases alternating with phases of
viremia, when waves of viral particles flood the
bloodstream.
In view of the above considerations,
what part can ozone play as an antiviral agent? In one study,[46]
polio virus 1 was exposed to 0.21 mg/liter of ozone at pH 7.2. After
30 seconds 99% of the viruses were inactivated (lost their ability
to replicate within host cells), but appeared to maintain their
structural integrity. Analysis of viral components showed damage to
polypeptide chains and envelope proteins, which could result in
attachment capability compromise, and breakage of the
single-stranded RNA into two parts, producing replicating
dysfunction at its root level. Other researchers[54] in similar
experiments concluded that in ozonation, it is the viral capsid
which sustains damage. It is to be noted however, that the
polioviridae (Picornavirus family) contain four structural proteins
encapsulating a single RNA strand and are devoid of
lipids.
In those clinical applications which
make use of external (or body cavity) application of ozone, it can
be appreciated that in view of the fact that a direct ozone-organism
contact exists, inactivation of microorganisms, bacteria, viruses or
fungi, proceeds by any one of a variety of different mechanisms. The
treatment of burns, superficial mycotic infection, decubitus ulcers
and abscesses is applied by this method. Theoretical issues present
themselves, however, when examining treatment strategies aimed at
systemic infections, notably viral afflictions which make use of
introducing ozone-oxygen mixtures into the bloodstream (usually
major AHT). The ozone-treated aliquot of blood which is reported to
be rendered viral-free through direct contact with ozone and ozone
peroxides,[5] is reintroduced into the circulation. Since very
little free ozone remains in solution due to its high reactivity, it
is its products mainly lipid compounds, possibly others which are
thought to interact with circulating as well as tissue-bound
virions, thus inactivating them.
Within the dose ranges prescribed (up to
10 mg (O3/100 ml of blood), we may be curious to measure this
overflow antiviral capacity. Although unproven to be outright
curative for any viral illness, ozone blood treatment, as reported
in several studies[21,31,55] may lessen clinical severity or
duration. Thus therapeutic benefits have been noted in hepatitis,
acute and chronic, and herpes.[55] In chronic viral infections
Cytomegalic, Epstein-Barr and Retroviridae (AIDS) among others blood
ozonation performed in viremic cycles or in periods of clinical
exacerbation may, through direct action, through the production of
cofactors inhibitory to viral replication, or through modification
of immune function, be used in inducing viral quiescence. Ozone is
reported to be an immuno-stimulant in low doses and
immuno-inhibitory at higher
levels.[15,26,27]
It is not inconceivable, in view of the
possibilities given to ozone’s antiviral properties that new
generations of machines may be developed to test the therapeutic
potential of the extra-corporeal treatment of circulating
blood.
Ozone Treatment
in Cancer
The logic sustaining the use of
oxygen-ozone application to the treatment of carcinomas rests on the
strategy of capitalizing on the disturbed metabolism of cancer
cells. Since the first bio-chemical hypothesis of cancer was
proposed by Warburg[56] in 1925; that all tumors have higher rates
of glycolysis under aerobic conditions than do nontumor cells,
efforts have been made to find the variations which could best
affect treatment strategy. Although his statement has subsequently
been amended considerably, there is a massive and evolving body of
research centering on biochemical differences between normal and
malignant cells.[57]
Some tumors have high rates of glucose
use and lactic acid production in the presence of oxygen, a
reflection of a number of possible mechanisms, from membrane
transport differences to variations in ATP regulation. Cancer cell
mitochondrial ribosomes have altered J structure and function which
could diminish their oxidative energy producing abilities thus
accounting for their limited aerobic
potential.[57]
Some authors[5,26] report a peroxide
intolerance in tumor cells. Possessing insufficient catalase and
peroxidase, they are incapable of effective peroxide inactivation.
Such cells exposed to ozone are said to show a significant decrease
in lactate content, indicating that ozone may induce metabolic
inhibition in some carcinomas.
In one study,[58] cultured cells of
different carcinoma types were compared with non-cancerous human
lung fibroblasts on exposure to ozonated air (0.3, 0.5, and 0.8 ppm
of O3 for 8 days). Alveolar (lung) adenocarcinoma, breast
adenocarcinoma, uterine carcinosarcoma and endometrial carcinoma
showed 40% cell growth inhibition at 0.3 ppm and 60% at 0.5 ppm. The
non-cancerous lung cells were unaffected at these levels. In 0.8 ppm
exposure, cancer cell growth inhibition was 90%. Interestingly, it
was at this level that the control cell group started to manifest
anabolic slowdown (50%). The authors postulate that cancer cells are
less able to compensate for the oxidative challenge of ozone than
normal cells, possibly by way of a less functional glutathione
system.
There are many clinical and anecdotal
reports,[21,25,27,59] of ozone major or minor autotherapy, at times
prescribed on a daily basis for several weeks applied to the
treatment of various carcinomatous conditions but with a paucity of
controlled data. Several researchers have focused their efforts on
using ozone as an adjunct to radiation or
chemotherapy.[23]
Summary and
Future Directions
Ozone, an allotropic form of oxygen,
possesses unique properties which are being defined and applied to
biological systems as well as to clinical practice. As a molecule
containing a large excess of energy, through incompletely understood
mechanisms, it manifests bactericidal, virucidal and fungicidal
action which may make it a treatment of choice in certain conditions
and an adjunct to treatment in others. Although ozone’s medicinal
effects were discovered in the 19th century and
clinically applied during World War I, equipment capable of purity
and reliability of delivery of oxygen-ozone mixtures were not
available until the late 1950’s. Since then, experience has
accumulated for the administration of ozone to humans and animals
via a variety of routes, in doses that are both nontoxic and
relevant to clinical problems, externally in gaseous form (or in
solution) and systemically in blood
ozonation.
A review of a large
body of literature is presented which describes a spectrum of
therapeutic indications. Of these, ozone application for superficial
infection, burns, dental and intestinal conditions, and possibly
circulatory problems seem to be the most promising. As regards blood
ozonation, further research is indicated to delineate the nature of
its dynamics and the extent of its effectiveness in (1) the
identification of the galaxy of compounds formed in this process
which, in view of doses administered, by all evidence, have
metabolic, immunological, endocrine and possibly neurological
effects; (2) the purification of blood or blood components for
transfusion purposes; (3) the inhibition of carcinomas with
reference to the types which may be the most susceptible and to its
use as an adjunct to radiation or chemotherapy; and (4) the
inactivation or the repression of viral diseases with special
attention to chronic conditions of the Herpes or Retroviridae (HIV)
families.
References
1.
Ihde AJ: The
Development of Modern Chemistry, Harper and Row, New York,
1964.
2.
Partington JR: A
History of Chemistry. Macmillan and Co., New York,
1962
3.
Schonbein C: Notice
of C Sch., the discoverer of ozone. Annual Report of the Board of
Regents of the Smithsonian Inst., 1868, Washington, DC, US
Government Printing Office, 1869,
185-192.
4.
Razumovskii SD,
Zaikov GE: Ozone and Its Reactions With Organic Compounds. Elsevier,
New York. 1984.
5.
Rilling S, Veribahn
R: The Use of Ozone in Medicine. Haug, New York,
1987.
6.
Payr E: Uber
ozonbehandlung in der chirurgie. Munch med Wschr
1935;82:220-291.
7.
Wolff H: Das
Medizinische Ozon. Heidelberg, VFM Publications,
1979.
8.
Hansler J, Weiss H:
Beitrag zum Unterschied zwischen HOT und Ozontherapie mit dem
Ozonosan Erfahr hk 1976,25:185-188.
9.
Gumulka J, Smith L:
Ozonation of cholesterol. J. Am Chem Soc 1983;105(7):
1972-1979.
10. Smith LL: Cholesterol autoxidation of
lipids. Chemistry and Physics of Lipids.
1987;44:87-125.
11. Meadows J, Smith R: Uric acid protection
of nucleobases from ozone induced degradation. Arch Biochem Biophys
1986;246(2): 838-845.
12. Menzel D: Ozone: An overview of its
toxicity in man and animals. Toxicol and Environ Health
1984;13:183-204.
13. Wolff A: Eine medizinische
verwendbarkeit des ozons. Dtsch Med Wschr
1915;311.
14. Held P: Verbrennungen: OzoNachrichten
1983;2:84.
15. Werkmeister H: Subatmospheric 02/03
treatment of therapy-resistant wounds and ulcerations.
OzoNachrichten 1985;4:53-59.
16. Aubourg P: L’ozone medical: Production,
posologie, modes d’applications cliniques. Bull Med Soc Med Paris
1938;52:745-749.
17. Medical World News. Nov. 9,
1987.
18. Vogelsberger W, Herget H: Klinische
ozonanwendung. OzoNachrichten 1983;2:1.
19. Rilling S: The basic clinical
applications of ozone therapy. Ozonachrichten
1985;4:7-17.
20. Rokitansky O: Klinik und biochemie der
ozon therapy. Hospitals 1982;52:643 nd
711.
21. Wolff H: Aktuelles in der ozontherapy.
Erfarhr hk 1977;26:193-196.
22. Riva-Sanseverino E: The influence of
ozone therapy on the remineralization of the bone tissue in
osteoporosis. OzoNachrichten
1987;6:75-79.
23. Tietz C: ozontherapie als adjuvans in
der onkologie. OzoNachrichten 1983;2:4.
24. Washuttl J, Steiner I, Szalay S:
Untersuchungen uber dieauswirkungen von ozon auf verschiedene
biochemische parameter bie blutproben in vitr Erfahr hk
1979;28:766.
25. Lacoste: Traitement des insuffisances
vascuilaires pa l’ozone. Gaz med de France 1951;315 (Ref. Petersen,
Med Kl 53;1958:2078).
26. Varro J: Die krebsbehandlung mit ozon.
Erfahr hk 1974;23:178-181.
27. Zabel W: Ganzheitsbehandlung der
gaschwulsterkrankungen. Hippokrates 1960;3
1:751-760.
28. Turk R: Ozone in dental medicine.
Ozonachrichten 1985;4:61-65.
29. Schulz S: Ozonisiertes
olivenol-experimentelle ergbnisse der wundheilung am tiermodell.
OzoNachrichen 1982;1:29.
30. Washuttl J, Viebahn R: ozonisiertes
oliveolozusammensetzung und desinfizierence wirksamkeit.
OzoNachrichen 1982;1:25.
31. Wehrli R: Transact six. Ham
1957;318
32. Mittler S, King M, Burkhardt B: Toxicity
of ozone. AMA Arch Ind Health
1957;15:191-197.
33. Clamann H: Physical and medical aspects
of ozone, in Physics and Medicine of the Atmosphere and Space. John
Wiley and Sons, New York, 1960,p. 151.
34. Basset D, Bowen-Kelly E: Rat lung
metabolism after 3 days of continuous exposure to 0.6
parts-per-million ozone. Am J Physiol 1986;250 (2 Part 2):
E131-E136.
35. McDonnell W, Horstman D, Abdul-Salaam S,
House D: Reproducibility of individual responses to ozone exposure.
Am Rev Respir Dis 1985;131(1): 36-40.
36. Folinsbee W: Effects of ozone exposure
on lung function in man: A review. Rev Environ Health
1981;3:211-240.
37. Kulle TJ, Sauder LR, Hebel JK, Chatham
MD: Ozone response relationships in healthy nonsmoker. Am Reu Respir
Dis 1985;132(1):36-41.
38. Hackney J, Linn W, Mohler J, Colier C:
Adaptation to short term respiratory effects of ozone in men exposed
repeatedly. J Appl Physiol Respirat Environ Exercise Physiol
1977;43:82-85.
39. Melton CE: Effects of long term exposure
to low levels of ozone: A review. Aviation, Space, and Environmental
Medicine 1982;53:105-111.
40. Dyas A, Boughton B, Das B: Ozone killing
action against bacterial and fungal species: Microbiological testing
of a domestic ozone generator. J Clin Pathol (Lond)
1983;36(10):1102-1104.
41. Wolcott J, Zee YC, Osebold J: Exposure
to ozone reduces influenza disease severity and alters distribution
of influenza viral antigens in murine lungs. Appl Environ Microbiol
1982;443:723-731.
42. Buckley RD, Hackney JD, Clark K, Posin
C: Ozone and human blood. Arch Environ Health
1975;30:40-43.
43. Viebahn R: The biochemical process
underlying ozone therapy. OzoNachrichten
1985;4:4:18-30.
44. Lohr A, Gratzek J: Bactericidal and
paraciticidal effects of an activated air oxidant in a closed
aquatic system. J Aquaric Aquat Sci
1984;4(41/2):1-8.
45. Ivanova O, Bogdanov M, Kazantseva V, et
al: Ozone inactivation of enteroviruses in sewage. Vopr Virusol
1983;0(6):693-698.
46. Roy D, Wong PK, Engelbrecht RS, Chian
ES: Mechanism of enteroviral inactivation by ozone. Appl Envir
Microbiol 1981;41:718-723.
47. Roy D, Engelbrecht RS, Chian ES:
Comparative inactivation of six enteroviruses by ozone. Am Water
Works Assoc J 1982;74(12):660-664.
48. Mudd JB, Leavitt R, Ongun A, McManus T:
Reaction of ozone with amino acids and proteins. Atmos Environ
1969;3:669-682.
49. Ishizaki K, Sawadaishi D, Miura K,
Shinriki N: Effect of ozone on plasmid DNA of Escheria coli in situ.
Water Res 1987;21(7):823-828.
50. Cech T: RNA as an enzyme. Scientific
American 1986 Nov;255(5):64-76.
51. Matus V, Nikava A, Prakopava Z, Konyew
S: Effect of ozone on the survivability of Candida utilis cells.
Vyestsi AkanNauuk Bssr Syer Biyal Navuk
1981;0(3):49-52.
52. Matus V, Lyskova T, Sergienko I, Kustova
A, Grigortsevich T, Konev V: Fungi; growth and sporulation after a
single treatment of spores with ozone. Mikol Fitopatot
1982;16(5):420-423.
53. Gallo R: The AIDS virus. Scientific
American 1987 Jan;256(1):46-74.
54. Riesser V, Perrich J, Silver B, McCammon
J: Possible mechanimsm of poliovirus inactivation by ozone, in Forum
on Ozone Disinfection. Proceedings of the International Ozone
Institute. Syracuse, NY, 1977;pp.
186-192.
55. Mattassi R, Franchina A, D’Angelo F: Die
Ozontherapie als Adjuvans in der Gefaspathologie. OzoNachrichten
1982;1:2.
56. Warburg O: On the origin of cancer
cells. Science 1956;123:309-315.
57. De Vita V, Hellman S, Rosenberg S:
Cancer Principles and Practice of Oncology, Lippincott,
Philadelphia, 1985.
58. Sweet J, Kao MS, Lee D, Hagar W: Ozone
selectively inhibits growth of human cancer cells. Science
1980;209:931-933.
59. Wenzel D, Morgan D: Interactions of
ozone and antineoplastic drugs on rat fibroblasts and Walker rat
carcinoma cells. Res Commun Chem Patho Pharmacol
1983;40(2):279-288.16.
TI: Is There a Role for
Medical Ozone in the Treatment of HIV and Associated
Infections?
DT: Sept.
1993
AU:
Michael T. Carpendale and John Griffiss
SO:
Rehabilitation Medicine and Research Services, Veterans
Administration Medical Center, San Francisco, CA.
AB: Medical Ozone
inactivates many pathogenic viruses including HIV in vitro. Pilot
studies in man suggest positive benefits in the early stages of HIV
infection (T-4 cells greater than 400). These include increased T4
and T cells, normalizing of T4:T8 ratio, and a general feeling of
well-being and minimal evidence of infection. Improvement also
occurs in AIDS patients (T4 cells less than 200) but less evidence
of T4 cell resurgence. These studies indicate that at least in vitro
there is a good safety margin between the ozone dose required to
inactivate HIV and the earliest suggestion of suppression of
lymphocytes In fact, the lymphocytes are being stimulated at doses
that completely inactivates HIV. More work needs to be done to
clarify the most effective dosage and means of treating HIV
infections with medical ozone.
Ozone Selectively Inhibits Growth
of Human Cancer Cells
Science Vol. 209, 22 Aug 1980, pp. 931-933
Abstract:
The growth of
human cancer cells from lung, breast, and uterine tumors was
selectively inhibited in a dose-dependent manner by ozone at 0.3 to
0.8 part per million of ozone in ambient air during 8 days of
culture. Human lung diploid fibroblasts served as non-cancerous
control cells. The presence of ozone at 0.3 to 0.5 part per million
inhibited cancer cell growth 40 and 60 percent, respectively. The
non-cancerous lung cells were unaffected at these levels. Exposure
to ozone at 0.8 part per million inhibited cancer cell growth more
than 90 percent and control cell growth less than 50 percent.
Evidently, the mechanisms for defense against ozone damage are
impaired in human cancer cells.
24 April 1980;
revise 11 June 1980.
TI: Inactivation of Human
Immunodeficiency Virus Type 1 by Ozone in Vitro
DT
9105
AU
Keith H. Wells, Joseph Latino, Jerrie Gavalchin, and Bernard
J. Poiesz
SO
Blood, Vol. 78, No. 7 (October 1), 1991:pp
1882-1890
AB:
A device was designed to deliver a constant source of given
concentrations of ozone to fluids containing human Immunodeficiency
virus type 1 (HIV-1). Ozone was found to inactivate HIV-1
virions in a
dose-dependent manner. Greater than 11 log inactivation was achieved
within 2 hours at a concentration of 1,200 ppm ozone. Similar
concentrations of ozone had minimal effect on factor VIII activity
in both plasma and immunoaffinity-purified preparations of factor
VIII treated for the same time period. The data indicate that the
antiviral effects of ozone include viral particle disruption,
reverse transcriptase inactivation, and/or perturbation of the
ability of the virus to bind to its receptor on target cells. Ozone
treatment offers promise as a means to inactivate human retroviruses
in human body fluids and blood product preparations.
TI
The Influence of Ozone on Tumor Tissue In Comparison With
Healthy Tissue (in vitro)
DT
0789
AU
J. Washuttl, R. Viebahn and I. Steiner
SO
Ozone Science & Engineering. Volume 12, pp.
65-72
AB: In comparison with
healthy tissue, freshly operated carcinomatous ovarial tissue was
treated in vitro with ozone in a suitable medium using air as the
reference. In an analogous test arrangement and for reference
purposes, the cytostatics Adriblastin (= Doxorubicin, and
adriamycin) and Holaxan (= Ifosfamide, a cyclophosphamide) were
included for the tumor tissue. After preparation of the tissue
samples, the following substances were examined: 2, 3-DPG, NAD
(Nadide, DPN), Lecithin, Lysolecithin plus different enzymes and
metabolites both in the mitochondrial fraction as sell as, in the
supernatant layer, the following: LDH, HBDH, Aldolase, ICDH, F-6-PK,
cytochrome oxidase, Na, K, Ca and peroxidic metabolites.
Statistically
significant changes were found in tumor tissue after the action of
ozone in the mitochondrial fraction in the case of NAD and 2, 3-DPG, and in
lysolecithin were the supernatant substances were concerned; this
only applied to supernatant NAD in the case of healthy
tissue.
In all other
parameters examined, no form of statistical change was found
whatsoever in either healthy or tumorous tissue.
[Ozone therapy in lumbar sciatic
pain]
[Article in Italian]
D’Erme M, Scarchilli A, Artale AM, Pasquali Lasagni
M
Istituto Chirurgico Ortopedico Traumatologico
(I.C.O.T.), Latina. Pa4504@pan-service.it
INTRODUCTION: Medical ozone is a mixture of
oxygen and ozone which can be used for several medical applications.
Ozone was first applied clinically to the treatment of lumbar
sciatic pain peridurally, while Pietrogrande was the first in Italy
to report on its intradiscal administration to treat nucleus
polposus herniation. On account of these considerations, we have
decided to introduce this method in our Institute (I.C.O.T. Latina)
as an alternative to surgery in the treatment of lumbar sciatic pain
supported by an intradiscal hernia.
MATERIAL AND
METHODS: September, 1995, to April, 1997, we treated more than 1000
patients with intradiscal ozone infiltration. We prospectively
analyzed the first 50 patients, with 6 months’ follow-up at least;
all of them were preliminarily submitted to clinical examination,
electromyography, CT and MRI. After local anesthesia, we injected
the disk, with 18-20 G needles and under CT or fluoroscopic
guidance, with 12 ml of a mixture of oxygen and ozone at a
concentration of 20-30 micrograms/ml. The treatment was repeated two
or three more times at intervals of 3, 15 or, when necessary, 30
days. After each treatment, CT follow-ups were carried out and the
final follow-up was made 3 months later.
RESULTS: We
divided our results into clinical and instrumental. As for clinical
response, we had 68% positive results (40% excellent, 28% good) and
32% negative results (10% of patients underwent surgery and 22 are
under medical and physical treatment). As for CT response, we had
82% positive results (36% excellent, 46% good), while no major
changes between pre- and post-treatment CT findings in the remaining
18% of cases.
CONCLUSIONS: Ozone
therapy, thanks to its ease of execution and noninvasiveness,
permits the successful outpatient treatment of lumbar sciatic pain.
Moreover, the lack of major complications and the good results
obtained compared to other methods, such as chemonucleolysis,
percutaneous automated discectomy, microsurgery and conventional
surgery, suggest that ozone therapy can be considered the treatment
of choice for lumbar sciatic pain and a valid alternative to surgery
in many cases.
Warburg, Blass
and Koch: Men With A Message.
G.A. Freibott
International Association for Oxygen
Therapy
Priest River, ID, USA
“Today’s
scientists have substituted mathematics for experiments, and they
wander off through equation after equation, and eventually build a
structure which has no relation to reality.”1
“The
scientists from Franklin to Morse were clear thinkers and did not
produce erroneous theories. The scientists of today think deeply
instead of clearly. One must be sane to think clearly, but one can
think deeply and be quite insane.”2
“But nobody
today can say that one does not know what cancer and its prime cause
is. On the contrary, there is no disease whose prime cause is better
known, so that today ignorance is no longer an excuse that one
cannot do more about prevention. That the prevention of cancer will
come there is no doubt, for man wishes to survive. But how long
prevention will be avoided depends on how long the prophets of
agnosticism will succeed in inhibiting the application of scientific
knowledge in the cancer field. In the meantime, millions of men must
die of cancer unnecessarily.”3
"All truth passes
through three stages:
First, it is
ridiculed. Second, it is violently opposed. Third, it is accepted as
self-evident."4
These quotes are
the frank opinions of the Father of Alternating Current; A two time
Nobel Laureate; and a nineteenth century German philosopher,
Warburg, Blass, Koch and Tesla were men whose truths are becoming
evident in today’s world of science. These were pioneers and
scientists of the highest magnitude. This abstract uncovers,
postmortem, the discoveries of these men and their contributions to
future scientific studies.
Otto Warburg, won
his first Nobel Prize in 1931 for the oxygen transferring enzyme of
cell respiration and his second Nobel Prize in 1944 for his
discovery of the hydrogen transferring enzyme. His discoveries are
quoted above and as follows:
“But, even for
cancer, there is only one primary cause. Summarized in a few words,
the nine cause of cancer is the replacement of the respiration of
oxygen in normal body cells by a fermentation of sugar.”6
“Because no
cancer cell exists, the respiration of which is intact, it cannot be
disputed that cancer could be prevented if the respiration of the
body cells would be kept intact.”7
Dr. F. M. Eugene
Blass, an Oxidation Specialist and engineer/designer of the
Pennsylvania Steel-Coke ovens, clinically verified Warburg’s
foundational work. Returning to the United States in 1925, cured of
his cancer and armed with the knowledge of the Institut fur
Sauerstoff-Heilverfahren, Blass adamantly represented the German
Kneipp/Nature Cure and Oxidative therapies.
To
illustrate:
“The recognizable
results of an insufficient oxidation either because of a lack of
minerals or oxygen or because of the presence of foreign matter in
the bloodstream are the symptoms which bear the imposing
nomenclature of modern “dis-ease”. The different kind of parasites,
which are the “germs”, commonly blamed for the creation of these
various symptoms find food and lodging, in the diseased soil which
accumulates in the body but, logically, are not the cause of
disease. A clean habitation will not tolerate such hospitality and
normal vital fluids constitute the best insurance against
sickness.”8
OXIDATION is the
source of Life, it’s lack causes impaired health or disease, it’s
cessation death.”9
Dr. William
F. Koch., MD, Ph.D., a well published pathologist and medical school
professor, presented his co-practitioners with “a study of the
phenomena of the free radical, the double bond, and its alpha placed
hydrogen atom in the pathogenesis and correction of neoplastic,
viral and bacterial diseases.”10
Quotes to
illustrate further:
“’Oxidation has
several positions of control in its process in line with our
postulate. The first is the potency, of the FCG (functional carbonyl
group) which must start the process by dehydrogenating the fuel.
When this carbonyl group is not free, as when the hydrogen it
removes from the fuel is not taken away by some electron acceptor
system, then oxidation is blocked. And for this oxygen is essential
as the ultimate electron acceptor in aerobic organisms. So lack of
oxygen has two steps in blocking oxidation or hindering
it.”11
“Our
postulate provides for the polymerization of the carcinogenic toxin
as it develops to the cancer producing stage, and this provision is
based upon the chemical and clinical circumstances that stare one
straight in the face. Atrophy precedes neoplasia. If one answers
that the neoplasia is a reaction to the atrophy stimulus as hay
fever is to the pollen stimulus, one must still offer a mechanism
for the reaction. The simplest mechanism that could be involved is
that the toxin produces both changes, and this mechanism we have
already explained as due to a block in energy production and
transfer. Recovery from the states caused by the carcinogenic agent,
be it virus or chemical, is therefore a satisfactory support to the
contention, since the same agency accomplishes the corrections of
all states, atrophy, pregrowth toxic state, cachexia, and the
turnifactions.”12
“After the
pathogen, be it a virus, carcinogen, or some allergen has made the
pathogenic integration, the need for oxygen in the diseased cells is
all the more imperative, and removal of all sources of the
pathogenic amines is the prime consideration. And not until a good
dispersion of the tissue colloids is had, and a good oxygen supply
is present in the cells should the reagent be given. For if it does
not have a molecule of oxygen at hand to combine the free radical
formed by each dehydrogenation, there will be no curative
progression of oxidation, and the reagent is given in vain. This
also applies to the free radicals produced by the use of the
reducing agent.”13
“The best proof of
the correctness or practicability of any postulate in medicine is
doubtless the curative value of its application.”14
REFERENCES:
-
Nicola Tesla, Radio Power Will
Revolutionize the World, Modem Mechanix and Inventions, July,
1934, pg. 2.
-
lbid
-
Otto Warburg, The Prime Cause
and Prevention of Cancer, 1969, pg. 16. (Translation by Dean Burk,
National Cancer Institute.)
-
Arthur Schopenhauer,
International Tesla Society Journal of Power and Resonance, Vol.5,
No.4,19W, pg. 40.
-
Otto Warburg, The Prime Cause
and Prevention of Cancer, 1966, pg.6.
-
lbid.
-
F.M. Eugene Blass,
Oxygen-Therapy-Blass: It’s Development into a Complete Uniform
Treatment of Disease, Oxidation News Vol. 1, No.1, 1990 pg. 3.
-
F.M. Eugene Blass, Oxygen
Therapy: Its Foundation, -Aim and Results, 1927, pg. 1.
-
W.F. Koch, The Survival Factor
in Neoplastic and Viral Diseases, 1961, 1967. Front Cover.
-
lbid.p.24.
-
W.F. Koch, Survival Factor in
Neoplastic and V-um Diseases, 1961,1967, P. 2s7.
-
W.F. Koch, Neoplastic and
Viral Parasitism, Their Basic Chemistry And Its Clinical Reversal.
(An Introduction to Free Radical Therapy 1967 ppg. 41-42.
-
W.F. Koch, Survival Factor in
Neoplastic and Viral Diseases, 1961, 1967, p.
257. HOME |